NutriBand (NTRB) Other Operating Expenses (2017 - 2026)
NutriBand (NTRB) posted Other Operating Expenses of $236598.0 for Q2 2026, down 24.11% sequentially from $311768.0 in Q1 2026, and down 43.05% YoY from $415451.0 in Q2 2025.
NutriBand (NTRB) Other Operating Expenses (2017 - 2026) Analysis & Trends
NutriBand has reported Other Operating Expenses for 10 years, with the latest figure at $236598.0 in Q2 2026.
- Quarterly Other Operating Expenses fell 43.05% year-over-year to $236598.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.3 million (down 74.99% YoY) and the FY2026 annual result came in at $1.5 million, down 70.54% from the prior year.
- Other Operating Expenses fell to $236598.0 in Q2 2026 per NTRB's latest filing, from $311768.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $4.0 million in Q1 2025 and troughed at $236598.0 in Q2 2026.
- A 5-year average of $669971.8 and a median of $342328.5 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Other Operating Expenses soared 1100.3% in 2022, then slumped 92.11% in 2026.
- Over 5 years, Other Operating Expenses stood at $349272.0 in 2022, then declined by 23.01% to $268920.0 in 2023, then jumped by 69.11% to $454767.0 in 2024, then slumped by 38.97% to $277553.0 in 2025, then slipped by 14.76% to $236598.0 in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $236598.0, $311768.0, and $277553.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 236,598.00 |
| Jan 31, 2026 | 311,768.00 |
| Oct 31, 2025 | 277,553.00 |
| Jul 31, 2025 | 465,571.00 |
| Apr 30, 2025 | 415,451.00 |
| Jan 31, 2025 | 3.95 Mn |
| Oct 31, 2024 | 454,767.00 |
| Jul 31, 2024 | 341,272.00 |
| Apr 30, 2024 | 243,746.00 |
| Jan 31, 2024 | 343,385.00 |
| Oct 31, 2023 | 268,920.00 |
| Jul 31, 2023 | 356,256.00 |
| Apr 30, 2023 | 254,648.00 |
| Jan 31, 2023 | 725,465.00 |
| Oct 31, 2022 | 349,272.00 |
| Jul 31, 2022 | 304,353.00 |
| Apr 30, 2022 | 277,436.00 |
| Jan 31, 2022 | 2.48 Mn |
| Oct 31, 2021 | 207,700.00 |
| Jul 31, 2021 | 214,455.00 |